Skip to content

Balloon Catheter for Cervical Ripening

Balloon Catheter for Cervical Ripening With or Without Traction: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02606643
Acronym
25148
Enrollment
134
Registered
2015-11-17
Start date
2014-10-31
Completion date
2016-11-30
Last updated
2018-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Dilation

Brief summary

Once admitted, women who will have a transcervical balloon catheter inserted for induction will be approached for participation in this study. If they agree to be take part in this study (tape or no tape) they will be randomized into the study. After the balloon catheter is inserted, the balloon will then be filled with approximately 50-60 mL of normal saline, this is normal procedure. Study related: If randomized to No Taping the foley will be positioned comfortable and not placed to tension. For the Tension arm, tension will be placed on the balloon catheter, which will then be taped to the patient's inner thigh. The tension will be assessed and retaped as needed approximately every 30 minutes by the research and/or the nursing staff.

Detailed description

Once admitted, women who are schedule for induction and who's physician has order a balloon catheter, they will have a transcervical balloon catheter inserted-this is normal care. Patients will be placed in the dorsal lithotomy position in the delivery bed. The cervix will be examined digitally (this is the standard of care). The balloon catheter will be inserted by feel and passed through the cervix until the balloon is above the internal os. The balloon will then filled with approximately 50-60 mL of normal saline. This procedure is standard of care. Randomization: 63 cards will be prepared to read tape for tension and 63 will be prepared to read No tape/No Tension. These cards will be sealed in opaque envelopes and kept in the PI's office. After consent is obtained the PI will be notified and a sealed envelope will be opened and the patient and staff will be notified. If randomized to No tension the catheter will be positioned comfortable and not placed to tension (this is currently the standard at SSM - Saint Mary's Hospital ). For the Tension arm (research related), slight tension will be placed on the catheter, which will then be taped to the patient's inner thigh. The tension will be assessed and retaped as needed every 30 minutes by the research and/or the nursing staff. Only slight tension will be applied to those catheters assign to the tension group. The catheter will be taped to the inner thigh so there is no sag in the catheter from the urethra to the tape. There is no method or device to measure the tension placed on these catheters, if the patient moves her leg it can lessen or increase the tension, these are known factors. As part of the induction process, patients will be started on an infusion of oxytocin, this is the practice at SSMHC, unless there is a reason not to use oxytocin such as nonreassuring fetal heart tracing. In this situation it is the physician's choice of what to use for induction. Oxytocin is initiated at 2 milliunits/minute and increased 1-2 milliunits/minute approximately every 20 minutes to a maximum of 6 milliunits/minute while the Foley is in place. After expulsion of the balloon, the resident or attending physician will performed a cervical examination to document the time and the cervical examination, and the oxytocin will be titrated to achieve acceptable contraction rates without tachysystole -this is standard care. The patient's labor and delivery will be managed according to routine obstetric and institutional protocols. All patients will have continuous fetal heart rate and uterine activity monitoring. Chart review will be performed on both the maternal and infant medical record from admission to discharge.

Interventions

PROCEDURESlight traction

Slight traction will be applied to the balloon catheter

PROCEDUREFoley Catheter to no traction

Foley Catheter to no traction

Sponsors

St. Louis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* singleton gestation * Bishop score less than or equal to 6 * cephalic presentation

Exclusion criteria

* prostaglandins given this admission * any medical conditions precluding vaginal delivery * significant cervical or intrauterine infection * significant vaginal bleeding * intrauterine fetal demise * low lying placenta * prior cervical surgery * latex allergy

Design outcomes

Primary

MeasureTime frameDescription
Durationhours to delivery 0-26Hours of labor

Secondary

MeasureTime frameDescription
Deliveries Via Cesarean DeliveryintraoperativeWhat number of deliveries in the tension and no tension groups were via Cesarean delivery
Vaginal Delivery Within 24 Hours24 hoursvaginal delivery within 24 hours-not all deliveries were within 24hours

Countries

United States

Participant flow

Participants by arm

ArmCount
Group 1 Catheter to Slight Traction
Once the decision was made to use a transcervical catheter and the patient was not in labor, the patient was approached. After informed consent was obtained from each participant, an 18 French 30 cc Foley bulb was placed digitally by the housestaff, with or without a stylette. The balloon was filled with 50 cc of saline as this is the standard at our institution. Patients randomized to tension had their catheter taped with applied tension to the inner thigh. Tension was replaced approximately every 30 minutes as needed. If the catheter was not expelled after12 hours, the balloon was deflated and the catheter was removed.
68
Group 2 Catheter to no Traction
Once the decision was made to use a transcervical catheter and the patient was not in labor, the patient was approached. After informed consent was obtained from each participant, an 18 French 30 cc Foley bulb was placed digitally by the housestaff, with or without a stylette. The balloon was filled with 50 cc of saline as this is the standard at our institution. Patients randomized to no tension did not have any tension applied to their catheter. After randomization clinicians were not blinded to the allocated group. If the catheter was not expelled after12 hours, the balloon was deflated and the catheter was removed.
76
Total144

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studydid not meet inclusion criteria13

Baseline characteristics

CharacteristicGroup 1 Catheter to Slight TractionGroup 2 Catheter to no TractionTotal
Age, Continuous26 years26 years026 years
Bishop score at time of transcervical4 units on a scale3.5 units on a scale3.75 units on a scale
Body mass index at admission33.1 kg/m237.0 kg/m235.05 kg/m2
Gestational age at enrollment (wk39.1 weeks39.0 weeks39.05 weeks
Race/Ethnicity, Customized
American Indian or Alaska Native
0 participants0 participants0 participants
Race/Ethnicity, Customized
Asian
0 participants0 participants0 participants
Race/Ethnicity, Customized
Black or African American
41 participants53 participants94 participants
Race/Ethnicity, Customized
More than one race
0 participants0 participants0 participants
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
0 participants0 participants0 participants
Race/Ethnicity, Customized
Unknown or Not Reported
1 participants1 participants2 participants
Race/Ethnicity, Customized
White
20 participants17 participants37 participants
Region of Enrollment
United States
68 participants76 participants144 participants
Sex: Female, Male
Female
68 Participants76 Participants144 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 670 / 73
serious
Total, serious adverse events
0 / 670 / 73

Outcome results

Primary

Duration

Hours of labor

Time frame: hours to delivery 0-26

Population: an alpha level of .05, and a level of power of 80%. These parameters required a sample size of 63 patients per group

ArmMeasureValue (MEAN)
Group 1 Slight TensionDuration16.2 hours
Group 2 no TensionDuration16.9 hours
Comparison: an alpha level of .05, and a level of power of 80%. These parameters required a sample size of 63 patients per groupp-value: 0.814Chi-squared
Secondary

Deliveries Via Cesarean Delivery

What number of deliveries in the tension and no tension groups were via Cesarean delivery

Time frame: intraoperative

ArmMeasureValue (NUMBER)
Group 1 Slight TensionDeliveries Via Cesarean Delivery17 participants
Group 2 no TensionDeliveries Via Cesarean Delivery27 participants
Secondary

Vaginal Delivery Within 24 Hours

vaginal delivery within 24 hours-not all deliveries were within 24hours

Time frame: 24 hours

Population: Twenty four hour Vaginal delivery between groups

ArmMeasureValue (NUMBER)
Group 1 Slight TensionVaginal Delivery Within 24 Hours41 participants
Group 2 no TensionVaginal Delivery Within 24 Hours37 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026